The market cap-weighted S&P 500 Index rose 17.9% in the year, while the equal-weighted S&P 500 Index gained just 11.4%. Read ...

In 2025, my biotech-focused portfolio delivered a 34.3% average return, outperforming the S&P 500 by 20.6%. I prioritize small- and mid-cap biotechs with FDA-approved drugs entering commercialization, ...

Strategy carries $8.2B in convertible debt. Shareholder dilution exceeded 10% year-to-date from stock issuances to fund Bitcoin purchases. CEO Michael Saylor reversed his stance and now says Strategy ...

A former Senior Publishing Editor on the Dow Jones Newswires team at The Wall Street Journal, Aaron earned a Bachelor's degree in Economics from the University of Michigan and a Master's in Journalism ...

S&P 500 Year-End Gains The SPDR S&P 500 ETF Trust is up 17.1% year-to-date with just hours left to go before 2025 bows out, likely hitting the top range of a question asked by Benzinga earlier this ...

ClearBridge Investments, an investment management company, released its “ClearBridge Dividend Strategy” fourth-quarter 2025 investor letter. The strategy focuses on generating high current income, ...

Equity long/short hedge funds triumphed in 2025, with healthcare-focused managers the standout performers. But industry data provider PivotalPath warns of continued correlation between hedge funds and ...